All Stories

  1. Exploring the links between polyphenols, Nrf2, and diabetes: A review
  2. P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds
  3. Tapping into Nature’s Arsenal: Harnessing the Potential of Natural Antioxidants for Human Health and Disease Prevention
  4. Advances in molecular function of UPF1 in Cancer
  5. Cellular Basis of Adjuvant Role of n-3 Polyunsaturated Fatty Acids in Cancer Therapy: Molecular Insights and Therapeutic Potential against Human Melanoma
  6. Propranolol Promotes Monocyte-to-Macrophage Differentiation and Enhances Macrophage Anti-Inflammatory and Antioxidant Activities by NRF2 Activation
  7. An insight into role of amino acids as antioxidants via NRF2 activation
  8. The Potential Role of Major Argan Oil Compounds as Nrf2 Regulators and Their Antioxidant Effects
  9. Novel Multi-Antioxidant Approach for Ischemic Stroke Therapy Targeting the Role of Oxidative Stress
  10. E-Stilbenes: General Chemical and Biological Aspects, Potential Pharmacological Activity Based on the Nrf2 Pathway
  11. Redox Homeostasis and Nrf2-Regulated Mechanisms Are Relevant to Male Infertility
  12. Exploring antioxidant strategies in the pathogenesis of ALS
  13. An intricate rewiring of cancer metabolism via alternative splicing
  14. A Review of the Potential of Nuclear Factor [Erythroid-Derived 2]-like 2 Activation in Autoimmune Diseases
  15. Pharmacological Modulation of Oxidative Stress
  16. Potential Role of Natural Antioxidants in Countering Reperfusion Injury in Acute Myocardial Infarction and Ischemic Stroke
  17. Oxidative Stress as a Regulatory Checkpoint in the Production of Antiphospholipid Autoantibodies: The Protective Role of NRF2 Pathway
  18. 5-Oxohexahydroquinolines bearing 4-pyridyl methyl carboxylate as P-glycoprotein inhibitors and multidrug resistance reversal agents in cancer cells
  19. Novel spiroindoline quinazolinedione derivatives as anticancer agents and potential FLT3 kinase inhibitors
  20. Infection Meets Inflammation: N6-Methyladenosine, an Internal Messenger RNA Modification as a Tool for Pharmacological Regulation of Host–Pathogen Interactions
  21. Alkaloids as Natural NRF2 Inhibitors: Chemoprevention and Cytotoxic Action in Cancer
  22. Therapeutic potential of marine peptides in malignant melanoma
  23. Cancer Prevention and Therapy by Targeting Oxidative Stress Pathways
  24. Circulating Serum VEGF, IGF-1 and MMP-9 and Expression of Their Genes as Potential Prognostic Markers of Recovery in Post-Stroke Rehabilitation—A Prospective Observational Study
  25. Chemical, Biological and Biomedical Aspects of Bioantioxidants
  26. Marine Cyanobacterial Peptides in Neuroblastoma: Search for Better Therapeutic Options
  27. Antioxidant Activity of Coumarins and Their Metal Complexes
  28. The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
  29. NRF2 Activation by Nitrogen Heterocycles: A Review
  30. Modulation of Nrf2/HO-1 by Natural Compounds in Lung Cancer
  31. Antioxidant Activity of Natural Phenols and Derived Hydroxylated Biphenyls
  32. Sulfonamide a Valid Scaffold for Antioxidant Drug Development
  33. Endostatin and Cancer Therapy: A Novel Potential Alternative to Anti-VEGF Monoclonal Antibodies
  34. Recoding of Nonsense Mutation as a Pharmacological Strategy
  35. Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy
  36. LPS-Activated Microglial Cell-Derived Conditioned Medium Protects HT22 Neuronal Cells against Glutamate-Induced Ferroptosis
  37. Cardioprotective Mechanisms against Reperfusion Injury in Acute Myocardial Infarction: Targeting Angiotensin II Receptors
  38. Regulatory Effects of Curcumin on Platelets: An Update and Future Directions
  39. Nrf2 Pathway in Huntington’s Disease (HD): What Is Its Role?
  40. Potential Antioxidant Multitherapy against Complications Occurring in Sepsis
  41. Recent Advances in Nanomaterials of Group XIV Elements of Periodic Table in Breast Cancer Treatment
  42. Antioxidant Intervention against Male Infertility: Time to Design Novel Strategies
  43. Natural and Synthetic Xanthone Derivatives Counteract Oxidative Stress via Nrf2 Modulation in Inflamed Human Macrophages
  44. NRF2, a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer
  45. Effect of Curcumin-Loaded Mesoporous Silica Nanoparticles on the Head and Neck Cancer Cell Line, HN5
  46. Neuropeptide Y Promotes Human M2 Macrophage Polarization and Enhances p62/SQSTM1-Dependent Autophagy and NRF2 Activation
  47. Nitro-Oxidative Stress and Mitochondrial Dysfunction in Human Cell Lines Exposed to the Environmental Contaminants PFOA and BPA
  48. Nrf2 Modulation in Breast Cancer
  49. NRF2: A crucial regulator for mitochondrial metabolic shift and prostate cancer progression
  50. Ribosome-Directed Therapies in Cancer
  51. The Role of the NRF2 Pathway in Maintaining and Improving Cognitive Function
  52. Antifungal and Cytotoxic Activity of Diterpenes and Bisnorsesquiterpenoides from the Latex of Euphorbia resinifera Berg
  53. The Challenge of Reaching Undocumented Migrants with COVID-19 Vaccination
  54. NRF2 and Mitochondrial Function in Cancer and Cancer Stem Cells
  55. Human genetic factors associated with pneumonia risk, a cue for COVID-19 susceptibility
  56. An Overview of NRF2-Activating Compounds Bearing α,β-Unsaturated Moiety and Their Antioxidant Effects
  57. Therapeutic Potential of Marine Peptides in Prostate Cancer: Mechanistic Insights
  58. The Therapeutic Potential of Kaemferol and Other Naturally Occurring Polyphenols Might Be Modulated by Nrf2-ARE Signaling Pathway: Current Status and Future Direction
  59. Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy
  60. The Role of Organosulfur Compounds as Nrf2 Activators and Their Antioxidant Effects
  61. How Curcumin Targets Inflammatory Mediators in Diabetes: Therapeutic Insights and Possible Solutions
  62. Ascorbate as a Bioactive Compound in Cancer Therapy: The Old Classic Strikes Back
  63. Modulation of cellular redox environment as a novel therapeutic strategy for Parkinson's disease
  64. Interplay between Non-Coding RNAs and NRF2 in Different Cancers: Spotlight on MicroRNAs and Long Non-Coding RNAs
  65. Ribosomopathies and cancer: pharmacological implications
  66. A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
  67. Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites
  68. The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications
  69. Therapeutic Role of Carotenoids in Blood Cancer: Mechanistic Insights and Therapeutic Potential
  70. A Comprehensive Analysis of the Role of Oxidative Stress in the Pathogenesis and Chemoprevention of Oral Submucous Fibrosis
  71. Antioxidant Cardioprotection against Reperfusion Injury: Potential Therapeutic Roles of Resveratrol and Quercetin
  72. The Regulation of Endoplasmic Reticulum Stress in Cancer: Special Focuses on Luteolin Patents
  73. Design, Synthesis, and Biological Evaluation of Novel Tomentosin Derivatives in NMDA-Induced Excitotoxicity
  74. Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response
  75. Evaluation of the radical scavenging activity of some representative isoprenoid and aromatic cytokinin ribosides (N6-substituted adenosines) by in vitro chemical assays
  76. Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes
  77. Alkaloids and Colon Cancer: Molecular Mechanisms and Therapeutic Implications for Cell Cycle Arrest
  78. Pharmaceutical and Pharmacological Aspects of Modulation of Oxidative Stress 2020
  79. A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
  80. PFAS Molecules: A Major Concern for the Human Health and the Environment
  81. Synthesis, Crystallographic, Quantum Chemical, Antitumor, and Molecular Docking/Dynamic Studies of 4-Hydroxycoumarin-Neurotransmitter Derivatives
  82. Astaxanthin as a Modulator of Nrf2, NF-κB, and Their Crosstalk: Molecular Mechanisms and Possible Clinical Applications
  83. Probable Reasons for Neuron Copper Deficiency in the Brain of Patients with Alzheimer’s Disease: The Complex Role of Amyloid
  84. Nrf2 Regulation by Curcumin: Molecular Aspects for Therapeutic Prospects
  85. Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile
  86. Nigellidine (Nigella sativa, black-cumin seed) docking to SARS CoV-2 nsp3 and host inflammatory proteins may inhibit viral replication/transcription and FAS-TNF death signal via TNFR 1/2 blocking
  87. The Potential Role of Curcumin in Modulating the Master Antioxidant Pathway in Diabetic Hypoxia-Induced Complications
  88. Polyphenols as Antioxidants for Extending Food Shelf-Life and in the Prevention of Health Diseases: Encapsulation and Interfacial Phenomena
  89. Validating a Genomic Convergence and Network Analysis Approach Using Association Analysis of Identified Candidate Genes in Alzheimer’s Disease
  90. COVID-19: Marking the Gaps in Migrant and Refugee Health in Some Massive Migration Areas
  91. Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders
  92. Bcl-2 Modulation in p53 Signaling Pathway by Flavonoids: A Potential Strategy towards the Treatment of Cancer
  93. Multidrug efflux transporter ABCG2: expression and regulation
  94. The Specificity and Broad Multitarget Properties of Ligands for the Free Fatty Acid Receptors FFA3/GPR41 and FFA2/GPR43 and the Related Hydroxycarboxylic Acid Receptor HCA2/GPR109A
  95. Multivariate analysis of polyphenolic content and in vitro antioxidant capacity of wild and cultivated berries from Bosnia and Herzegovina
  96. Joint Cardioprotective Effect of Vitamin C and Other Antioxidants against Reperfusion Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
  97. Oxidative Stress in Mucopolysaccharidoses: Pharmacological Implications
  98. The Nrf2 Pathway in Ischemic Stroke: A Review
  99. Protective Effects of Flavonoids Against Mitochondriopathies and Associated Pathologies: Focus on the Predictive Approach and Personalized Prevention
  100. Evaluation of the Free Radical Scavenging Activities of Ellagic Acid and Ellagic Acid Peracetate by EPR Spectrometry
  101. Pyrido[2′,1′:2,3]imidazo[4,5-c]isoquinolin-5-amines as Potential Cytotoxic Agents against Human Neuroblastoma
  102. Synthesis, Structure and Impact of 5-Aminoorotic Acid and Its Complexes with Lanthanum(III) and Gallium(III) on the Activity of Xanthine Oxidase
  103. Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
  104. Reimagining Internationalization in Higher Education Through the United Nations Sustainable Development Goals for the Betterment of Society
  105. Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies
  106. Synthesized 2-Trifluoromethylquinazolines and Quinazolinones Protect BV2 and N2a Cells against LPS- and H2O2-induced Cytotoxicity
  107. COVID-19 and migrant and refugee health: A pointer to system competence in future pandemic preparedness
  108. Tamoxifen and oxidative stress: an overlooked connection
  109. Pharmacological Protection against Ischemia-Reperfusion Injury by Regulating the Nrf2-Keap1-ARE Signaling Pathway
  110. Synthesis and Biological Screening of New 4-Hydroxycoumarin Derivatives and Their Palladium(II) Complexes
  111. Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy
  112. Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury
  113. Regulatory Role of Nrf2 Signaling Pathway in Wound Healing Process
  114. The Role of Toxic Metals and Metalloids in Nrf2 Signaling
  115. Profiling Colorectal Cancer in the Landscape Personalized Testing—Advantages of Liquid Biopsy
  116. Natural Chain-Breaking Antioxidants and Their Synthetic Analogs as Modulators of Oxidative Stress
  117. Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer’s Disease
  118. The Unity of Redox and Structural Remodeling of Brown Adipose Tissue in Hypothyroidism
  119. Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
  120. Activation of Nrf2 signaling pathway by natural and synthetic chalcones: a therapeutic road map for oxidative stress
  121. Short overview on the relevance of microRNA–reactive oxygen species (ROS) interactions and lipid peroxidation for modulation of oxidative stress-mediated signalling pathways in cancer treatment
  122. Involvement of NRF2 in Breast Cancer and Possible Therapeutical Role of Polyphenols and Melatonin
  123. Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
  124. Evaluation of the cellular protection by novel spiropyrazole compounds in dopaminergic cell death
  125. The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes
  126. Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion
  127. Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met
  128. Insight into the Biological Activity of Hennosides—Glucosides Isolated from Lawsonia inermis (henna): Could They Be Regarded as Active Constituents Instead
  129. Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats
  130. Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
  131. Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice
  132. Antioxidant and Biological Activities of Hydroxytyrosol and Homovanillic Alcohol Obtained from Olive Mill Wastewaters of Extra-Virgin Olive Oil Production
  133. Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications
  134. New trends in the pharmacological intervention of PPARs in obesity: Role of natural and synthetic compounds_
  135. An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation
  136. In Vitro Interaction of 5-Aminoorotic Acid and Its Gallium(III) Complex with Superoxide Radical, Generated by Two Model Systems
  137. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention
  138. Lanthanide (III) complexes of bis-coumarins as strong inhibitors of bovine xanthine oxidase - molecular docking and SAR studies
  139. Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications
  140. Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2
  141. Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment
  142. Lupeol Counteracts the Proinflammatory Signalling Triggered in Macrophages by 7-Keto-Cholesterol: New Perspectives in the Therapy of Atherosclerosis
  143. Kaempferol as a Dietary Anti-Inflammatory Agent: Current Therapeutic Standing
  144. Ellagic Acid-Derived Urolithins as Modulators of Oxidative Stress
  145. Antioxidant Activity of Synthetic Polymers of Phenolic Compounds
  146. Modulators of Oxidative Stress: Chemical and Pharmacological Aspects
  147. Natural Sources, Pharmacokinetics, Biological Activities and Health Benefits of Hydroxycinnamic Acids and Their Metabolites
  148. Synthesis, In Vitro Antioxidant Properties and Distribution of a New Cyanothiophene-Based Phenolic Compound in Olive Oil-In-Water Emulsions
  149. Interaction of 2,6,7-Trihydroxy-Xanthene-3-Ones with Iron and Copper, and Biological Effect of the Most Active Derivative on Breast Cancer Cells and Erythrocytes
  150. The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
  151. Diverse and Complex Challenges to Migrant and Refugee Mental Health: Reflections of the M8 Alliance Expert Group on Migrant Health
  152. Influence of Oxidative Stress on Catalytic and Non-glycolytic Functions of Glyceraldehyde-3-phosphate Dehydrogenase
  153. Chemistry and Pharmacology of Modulators of Oxidative Stress
  154. 5-Oxo-hexahydroquinoline Derivatives and Their Tetrahydroquinoline Counterparts as Multidrug Resistance Reversal Agents
  155. Oxidative stress and endoplasmic stress in calcium oxalate stone disease: the chicken or the egg?
  156. Potential Applications of NRF2 Modulators in Cancer Therapy
  157. Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy
  158. The Effects of Trifluoromethylated Derivatives on Prostaglandin E2 and Thromboxane A2 Production in Human Leukemic U937 Macrophages
  159. The Interaction of Flavonols with Membrane Components: Potential Effect on Antioxidant Activity
  160. The pharmacokinetics of flavanones
  161. Prior Activation of 5-HT7 Receptors Modulates the Conditioned Place Preference With Methylphenidate
  162. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
  163. Oxidative Stress: Role and Response of Short Guanine Tracts at Genomic Locations
  164. Post-translational modifications of proteins in antiphospholipid antibody syndrome
  165. Global Text Mining and Development of Pharmacogenomic Knowledge Resource for Precision Medicine
  166. Reduced adolescent risk-assessment and lower nicotinic beta-2 expression in rats exposed to nicotine through lactation by forcedly drinking dams
  167. Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects 2018
  168. Renoprotective effect of tectorigenin glycosides isolated from Iris spuria L. (Zeal) against hyperoxaluria and hyperglycemia in NRK-49Fcells
  169. Topology-Dependent Dissociation Mode of the O–H Bond in Monohydroxycoumarins
  170. Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells
  171. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs
  172. Systems Approach to Identify Common Genes and Pathways Associated with Response to Selective Serotonin Reuptake Inhibitors and Major Depression Risk
  173. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
  174. Potential Applications of NRF2 Inhibitors in Cancer Therapy
  175. Regulation of the Nrf2 Pathway by Glycogen Synthase Kinase-3β in MPP+-Induced Cell Damage
  176. Antioxidant Activities of Alkyl Substituted Pyrazine Derivatives of Chalcones—In Vitro and In Silico Study
  177. The influence of alkaloids on oxidative stress and related signaling pathways
  178. Critical reflections, challenges and solutions for migrant and refugee health: 2nd M8 Alliance Expert Meeting
  179. Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach
  180. Relation of Redox and Structural Alterations of Rat Skin in the Function of Chronological Aging
  181. Synthesis and Characterization of 3-(1-((3,4-Dihydroxyphenethyl)amino)ethylidene)-chroman-2,4-dione as a Potential Antitumor Agent
  182. Screening Pyridine Derivatives against Human Hydrogen Sulfide-synthesizing Enzymes by Orthogonal Methods
  183. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells
  184. Behaviour of 9-Ethyl-9H-carbazole Hydrazone Derivatives Against Oxidant Systems
  185. Antioxidant Properties of Synthesized Bicyclic Thiazolopyrimidine Derivatives as Possible Therapeutic Agents
  186. Modulation of ERK1/2 and Akt Pathways Involved in the Neurotrophic Action of Caffeic Acid Alkyl Esters
  187. Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review
  188. Searching for inhibitors of human H 2 S-synthesizing enzymes by orthogonal methods
  189. Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders
  190. Protective effects of new antioxidant compositions of 4‐methylcoumarins and related compounds with dl‐α‐tocopherol and l‐ascorbic acid
  191. Mono and dihydroxy coumarin derivatives: Copper chelation and reduction ability
  192. 9-(4'-dimethylaminophenyl)-2,6,7-trihydroxy-xanthene-3-one is a Potentially Novel Antiplatelet Drug which Antagonizes the Effect of Thromboxane A2
  193. Efficient synthesis and first regioselective C-6 direct arylation of imidazo[2,1- c ][1,2,4]triazine scaffold and their evaluation in H 2 O 2 -induced oxidative stress
  194. Inhibition of Shiga toxin-converting bacteriophage development by novel antioxidant compounds
  195. Nonylphenol and Octylphenol Differently Affect Cell Redox Balance by Modulating the Nitric Oxide Signaling
  196. Oxidative Stress Induces HSP90 Upregulation on the Surface of Primary Human Endothelial Cells: Role of the Antioxidant 7,8-Dihydroxy-4-methylcoumarin in Preventing HSP90 Exposure to the Immune System
  197. In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2
  198. Protective effects of 4-methylcoumarins and related compounds as radical scavengers and chain-breaking antioxidants
  199. Long Chain Alkyl Esters of Hydroxycinnamic Acids as Promising Anticancer Agents: Selective Induction of Apoptosis in Cancer Cells
  200. Controversy about pharmacological modulation of Nrf2 for cancer therapy
  201. The Role Of Oxidative Stress Modulators In Breast Cancer
  202. Antioxidant activity of phenolic compounds from extracts of Eucalyptus globulus and Melaleuca styphelioides and their protective role on D-glucose-induced hyperglycemic stress and oxalate stress in NRK-49Fcells
  203. Derivatives of caffeic acid, a natural antioxidant, as the basis for the discovery of novel nonpeptidic neurotrophic agents
  204. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
  205. The simple isocratic HPLC—UV method for the simultaneous determination of reduced and oxidized glutathione in animal tissue
  206. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
  207. Synthesis of new heterocyclic compounds based on pyrazolopyridine scaffold and evaluation of their neuroprotective potential in MPP + -induced neurodegeneration
  208. Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance
  209. Novel 5-oxo-hexahydroquinoline derivatives: design, synthesis, in vitro P-glycoprotein-mediated multidrug resistance reversal profile and molecular dynamics simulation study
  210. Detection of Reactive Oxygen and Nitrogen Species by Electron Paramagnetic Resonance (EPR) Technique
  211. Expression of heterologous oxalate decarboxylase in HEK293 cells confers protection against oxalate induced oxidative stress as a therapeutic approach for calcium oxalate stone disease
  212. Disulfiram moderately restores impaired hepatic redox status of rats subchronically exposed to cadmium
  213. Cardiovascular Mitochondrial Dysfunction Induced by Cocaine: Biomarkers and Possible Beneficial Effects of Modulators of Oxidative Stress
  214. Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects 2017
  215. Antimycobacterial activity of novel hydrazide-hydrazone derivatives with 2 H -chromene and coumarin scaffold
  216. Effect of organic co-solvents in the evaluation of the hydroxyl radical scavenging activity by the 2-deoxyribose degradation assay: The paradigmatic case of α-lipoic acid
  217. Tetrahydroquinolinone derivatives as potent P-glycoprotein inhibitors: design, synthesis, biological evaluation and molecular docking analysis
  218. Antioxidant activity and protective role on protein glycation of synthetic aminocoumarins
  219. Discovery of neurotrophic agents based on hydroxycinnamic acid scaffold
  220. Antiproliferative and antioxidative effects of novel hydrazone derivatives bearing coumarin and chromene moiety
  221. Synthesis and evaluation of antibacterial and antioxidant activity of novel 2-phenyl-quinoline analogs derivatized at position 4 with aromatically substituted 4H-1,2,4-triazoles
  222. Negletein as a neuroprotectant enhances the action of nerve growth factor and induces neurite outgrowth in PC12 cells
  223. Novel indole-based melatonin analogues: Evaluation of antioxidant activity and protective effect against amyloid β-induced damage
  224. Lanthanide(III) complexes are more active inhibitors of the Fenton reaction than pure ligands
  225. Cardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative Stress
  226. Modulation of Oxidative Stress: Pharmaceutical and Pharmacological Aspects
  227. Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants
  228. Neuroprotective and Antioxidant Activities of 4-Methylcoumarins: Development of Structure–Activity Relationships
  229. Modulation of neurotrophic signaling pathways by polyphenols
  230. Oxidative stress, bioelements and androgen status in testes of rats subacutely exposed to cadmium
  231. The impact of Hydrogen peroxide on structure, stability and functional properties of Human R12C mutant αA-crystallin: The imperative insights into pathomechanism of the associated congenital cataract incidence
  232. Effective attenuation of atrazine-induced histopathological changes in testicular tissue by antioxidantN-phenyl-4-aryl-polyhydroquinolines
  233. Structure–activity relationship studies of 4-methylcoumarin derivatives as anticancer agents
  234. Inhibition of Alzheimer’s BACE-1 by 2,6-dialkyl-4-chromon-3-yl-1,4-dihydropyridine-3,5-dicarboxylates
  235. Kinase Inhibitors with Redox and Anti-inflammatory Activities
  236. Hypoglycemic activity of curcumin synthetic analogues in alloxan-induced diabetic rats
  237. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells
  238. Pleiotropic Effects of Statins in Atherosclerotic Disease: Focus on the Antioxidant Activity of Atorvastatin
  239. Multiple Mechanisms of Iron-Induced Amyloid Beta-Peptide Accumulation in SHSY5Y Cells: Protective Action of Negletein
  240. Carthamus, SalviaandStachysspecies protect neuronal cells against oxidative stress-induced apoptosis
  241. In vitro evaluation of copper-chelating properties of flavonoids
  242. Chromenone and quinolinone derivatives as potent antioxidant agents
  243. 4-Methylcoumarin Derivatives with Anti-inflammatory Effects in Activated Microglial Cells
  244. Comparison of Protein Acetyltransferase Action of CRTAase with the Prototypes of HAT
  245. Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases
  246. Resveratrol Counteracts Inflammation in Human M1 and M2 Macrophages upon Challenge with 7-Oxo-Cholesterol: Potential Therapeutic Implications in Atherosclerosis
  247. Editorial (Thematic Issue: Synthesis, Evaluation and Pharmacological Applications of Antioxidants- Part 1)
  248. Editorial (Thematic Issue: Synthesis, Evaluation and Pharmacological Applications of Antioxidants- Part 2)
  249. Antioxidant Activity of Galantamine and Some of its Derivatives
  250. Advances in Research of Schiff-Base Metal Complexes as Potent Antioxidants
  251. Oxidized Haemoglobin–Driven Endothelial Dysfunction and Immune Cell Activation: Novel Therapeutic Targets for Atherosclerosis
  252. Reversal of multidrug resistance in cancer cells by novel asymmetrical 1,4-dihydropyridines
  253. Protection of Cells against Oxidative Stress by Nanomolar Levels of Hydroxyflavones Indicates a New Type of Intracellular Antioxidant Mechanism
  254. Comparative specificities of Calreticulin Transacetylase to O-acetyl, N-acetyl and S-acetyl derivative of 4-methylcoumarins and their inhibitory effect on AFB1-induced genotoxicity in vitro and in vivo
  255. Editorial (Hot Topic: Antioxidant Heterocyclic Compounds in Drug Discovery and Medicinal Chemistry)
  256. Biotechnology in the Production of Pharmaceutical Industry Ingredients: Amino Acids
  257. Resveratrol Prevents Dendritic Cell Maturation in Response to Advanced Glycation End Products
  258. In vitro platelet antiaggregatory properties of 4-methylcoumarins
  259. Iron reduction potentiates hydroxyl radical formation only in flavonols
  260. An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization
  261. Alkyl esters of hydroxycinnamic acids with improved antioxidant activity and lipophilicity protect PC12 cells against oxidative stress
  262. Antiradical and antioxidant activities of new bio-antioxidants
  263. Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice
  264. Biomarkers of Subclinical Atherosclerosis in Patients with Autoimmune Disorders
  265. In vitro characteristics of 1-phenyl-3-methyl-4-acylpyrazol-5-ones iron chelators
  266. T Lymphocyte Autoreactivity in Inflammatory Mechanisms Regulating Atherosclerosis
  267. The mechanism of antioxidant activity of IRFI005 as a synthetic hydrophilic analogue of vitamin E
  268. Antioxidant Therapy: Current Status and Future Prospects
  269. Normalization of deranged signal transduction in lymphocytes of COPD patients by the novel calcium channel blocker H-DHPM
  270. Short- and long-term regulation of 3-hydroxy 3-methylglutaryl coenzyme A reductase by a 4-methylcoumarin
  271. Protein Acyltransferase Function of Purified Calreticulin: The Exclusive Role of P-Domain in Mediating Protein Acylation Utilizing Acyloxycoumarins and Acetyl CoA as the Acyl Group Donors
  272. In vitro analysis of iron chelating activity of flavonoids
  273. Advanced glycation end products of human  2 glycoprotein I modulate the maturation and function of DCs
  274. Dietary Phenolic Acids and Derivatives. Evaluation of the Antioxidant Activity of Sinapic Acid and Its Alkyl Esters
  275. Optimization of Lipase Production from Aspergillus terreus by Response Surface Methodology and Its Potential for Synthesis of Partial Glycerides Under Solvent Free Conditions
  276. Novel coumarin-based tyrosinase inhibitors discovered by OECD principles-validated QSAR approach from an enlarged, balanced database
  277. 4-Methylcoumarins as antioxidants: Scavenging of peroxyl radicals and inhibition of human low-density lipoprotein oxidation
  278. A spectroelectrochemical and chemical study on oxidation of 7,8-dihydroxy-4-methylcoumarin (DHMC) and some related compounds in aprotic medium
  279. Antioxidant properties of 4-methylcoumarins in in vitro cell-free systems
  280. In vitro interactions of coumarins with iron
  281. Structure–activity relationship of dihydroxy-4-methylcoumarins as powerful antioxidants: Correlation between experimental & theoretical data and synergistic effect
  282. β-sitosterol among other secondary metabolites of Piper galeatum shows inhibition of TNFα-induced cell adhesion molecule expression on human endothelial cells
  283. Protein acyltransferase function of purified calreticulin. Part 1: characterization of propionylation of protein utilizing propoxycoumarin as the propionyl group donor
  284. Home cage testing of delay discounting in rats
  285. Resilience and vulnerability are dose-dependently related to neonatal stressors in mice
  286. Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies
  287. Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies
  288. Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490
  289. The Role of Calreticulin Transacetylase in the Activation of Human Platelet Nitrite Reductase by Polyphenolic Acetates
  290. Non-native glyceraldehyde-3-phosphate dehydrogenase can be an intrinsic component of amyloid structures
  291. Autoacetylation of Purified Calreticulin Transacetylase Utilizing Acetoxycoumarin as the Acetyl Group Donor
  292. Autoacetylation of Purified Calreticulin Transacetylase Utilizing Acetoxycoumarin as the Acetyl Group Donor
  293. Inhibition of Candida albicans extracellular enzyme activity by selected natural substances and their application inCandidainfection
  294. Calreticulin Transacetylase Catalyzed Activation of Rat Tracheal Smooth Muscle Cell Nitric Oxide Synthase by Acetoxycoumarins
  295. Behavioral effects of 6-bromoflavanone and 5-methoxy-6,8-dibromoflavanone as anxiolytic compounds
  296. DPPH Radical Scavenging Activity of Several Naturally Occurring Coumarins and Their Synthesized Analogs Measured by the SIA Method
  297. Protein oxidation markers in the serum and synovial fluid of psoriatic arthritis patients
  298. Antioxidant activity of 4-methylcoumarins
  299. Themed Issue:Chemistry and Biology of Antioxidants
  300. Specific oxidative stress parameters differently correlate with nailfold capillaroscopy changes and organ involvement in systemic sclerosis
  301. Antioxidant and prooxidant effects of quercetin on glyceraldehyde-3-phosphate dehydrogenase
  302. Interaction of Polyelectrolytes with Proteins, 3
  303. Synthesis of Deoxy Sugar Esters:  A Chemoenzymatic Stereoselective Approach Affording Deoxy Sugar Derivatives Also in the Form of Aldehyde
  304. Decrease of dehydrogenase activity of cerebral glyceraldehyde-3-phosphate dehydrogenase in different animal models of Alzheimer's disease
  305. Helicobacter pylori EstV: Identification, Cloning, and Characterization of the First Lipase Isolated from an Epsilon-Proteobacterium
  306. A spectroelectrochemical and chemical study on oxidation of hydroxycinnamic acids in aprotic medium
  307. Effect of α-crystallin on thermal denaturation and aggregation of rabbit muscle glyceraldehyde-3-phosphate dehydrogenase
  308. Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis
  309. Mechanism of Thermal Aggregation of Rabbit Muscle Glyceraldehyde-3-phosphate Dehydrogenase†
  310. Oxidative stress parameters in different systemic rheumatic diseases
  311. Preface
  312. Inhibition of Candida rugosa lipase by saponins, flavonoids and alkaloids
  313. Propionibacterium acnes GehA lipase, an enzyme involved in acne development, can be successfully inhibited by defined natural substances
  314. Parameters of oxidative stress status in healthy subjects: their correlations and stability after sample collection
  315. Interaction of Polyanions with Basic Proteins, 2
  316. Long-term effects of lonidamine on mouse testes
  317. Lonidamine transiently affects spermatogenesis in pubertal CD1 mice
  318. Preface: male infertility, from contraception to therapy
  319. Identification of a carboxylesterase-producingRhodococcussoil isolate
  320. Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections
  321. Atractylis gummifera L. poisoning: an ethnopharmacological review
  322. Evaluation of the antioxidant activity of flavonoids by “ferric reducing antioxidant power” assay and cyclic voltammetry
  323. Activation and inhibition of Candida rugosa and Bacillus-related lipases by saturated fatty acids, evaluated by a new colorimetric microassay
  324. Hypochlorite scavenging activity of flavonoids
  325. Hypochlorite scavenging activity of hydroxycinnamic acids evaluated by a rapid microplate method based on the measurement of chloramines
  326. Preface
  327. Development of a new assay for the screening of hypochlorous acid scavengers based on reversed-phase high-performance liquid chromatography
  328. Indazole carboxylic acids in male contraception
  329. Lipocalin type prostaglandin D-synthase: which role in male fertility?
  330. Recent studies on lonidamine, the lead compound of the antispermatogenic indazol-carboxylic acids
  331. The controversial efficacy of vitamin E for human male infertility
  332. Antimicrobial and Anti-Lipase Activity of Quercetin and its C2-C16 3-O-Acyl-Esters
  333. Corneal Toxicity of Xylazine and Clonidine, in Combination with Ketamine, in the Rat
  334. Analgesic properties of Epilobium angustifolium, evaluated by the hot plate test and the writhing test
  335. Anti-proliferative effect on a prostatic epithelial cell line (PZ-HPV-7) by Epilobium angustifolium L.
  336. Inhibition of heat-induced denaturation of albumin by nonsteroidal antiinflammatory drugs (NSAIDs): Pharmacological implications
  337. Inhibition of calcium oxalate precipitation by bile salts
  338. Analysis of lonidamine in rat serum and testis by high performance liquid chromatography
  339. Antidenaturant drugs for cataract and other condensation diseases
  340. In vitro evaluation of antioxidant activity by electrophoresis and high performance liquid chromatography
  341. Relaxant Effects of Hydrastis canadensis L. and its Major Alkaloids on Guinea Pig Isolated Trachea
  342. Antimicrobial investigation of semipurified fractions of Ginkgo biloba leaves
  343. Stimulation of guinea pig isolated atria by aflatoxins
  344. Effects of lonidamine on testicular and epididymal proteins in the rat☆
  345. Relaxant Effects of Aflatoxins on Isolated Guinea Pig Trachea
  346. AFLATOXINS INHIBIT PROLACTIN SECRETION BY RAT PITUITARY CELLS IN CULTURE
  347. Simultaneous determination of hydrocortisone, dexamethasone, indomethacin, phenylbutazone and oxyphenbutazone in equine serum by high-performance liquid chromatography
  348. Micropurification of β- and γ-crystallins from rabbit aqueous humor
  349. Changes of Glycosylation of Serum Proteins in Sjogren's Syndrome: Correlation with Interleukin-6 and Soluble Interleukin-2 Receptor
  350. Stabilization of rat serum proteins following oral administration of fish oil
  351. Development of an in vitro Assay for the Screening of Substances Capable of Dissolving Calcium Oxalate Crystals
  352. Development of an enzyme-linked immunosorbent assay, using a monoclonal antibody against α2-macroglobulin, for the diagnosis of systemic lupus erythematosus
  353. Changes in concanavalin A-reactive proteins in neurological disorders
  354. Inhibition of Protein Denaturation by Fatty Acids, Bile Salts and Other Natural Substances: A New Hypothesis for the Mechanism of Action of Fish Oil in Rheumatic Diseases.
  355. Inhibition ofCandida rugosaLipase by Berberine and Structurally Related Alkaloids, Evaluated by High-Performance Liquid Chromatography
  356. Development of a Turbidimetric Assay to Study the Effect of Urinary Components on Calcium Oxalate Precipitation
  357. Development of an HPLC Assay to Study the Effect of Endogenous and Exogenous Substances on Heat-Induced Aggregation of Human Serum Albumin
  358. Response of α2-Macroglobulin Messenger Ribonucleic Acid Expression to Acute Inflammation in the Testis is Different from the Response in the Liver and Brain1
  359. Abnormal glycosylation of ?2-macroglobulin, a non-acute-phase protein, in patients with autoimmune diseases
  360. The Use of High-Performance Electrophoresis Chromatography for the Micropurification of Cerebrospinal Fluid Proteins in the Rat
  361. Changes of immunoreactivity in ?1-antitrypsin in patients with autoimmune diseases
  362. Facilitating Effect of Amphetamine and Harmaline on Blood Pressure Response to Biogenic Amines in Rats
  363. In Vitro Antiproliferative Activity of Petiveria Alliacea L. on Several Tumor Cell Lines
  364. Persea Indica: General Pharmacological Effects of the Total Extract
  365. Regulation of Sertoli Cell α2-Macroglobulin and Clusterin (SGP-2) Secretion by Peritubular Myoid Cells1